JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Advances in the roles and molecular mechanisms of exosomal circular RNAs in regulating the pre-metastatic niche of tumors

  • 0Cancer Institute, Affiliated People's Hospital of Jiangsu University, No 8, Dianli Road, Zhenjiang, 212002, Jiangsu, People's Republic of China.
Discover Oncology +

|

April 19, 2025

|

April 19, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Exosomes carrying circular RNAs (circRNAs) help form the pre-metastatic niche, promoting cancer spread. Understanding these exosomal circRNAs offers new therapeutic targets to combat metastasis.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cell Biology

Background

  • Metastasis is a primary cause of cancer mortality.
  • The pre-metastatic niche is crucial for distant tumor spread.
  • Exosomes mediate intercellular communication and transport circular RNAs (circRNAs).

Purpose Of The Study

  • To review the characteristics and functions of exosomal circRNAs.
  • To outline molecular mechanisms of exosomal circRNAs in pre-metastatic niche formation.
  • To highlight exosomal circRNAs as therapeutic targets for metastasis.

Main Methods

  • Literature review of exosomal circRNAs and pre-metastatic niche formation.
  • Analysis of molecular pathways involved in niche regulation.
  • Synthesis of current knowledge on exosomal circRNAs' role in metastasis.

Main Results

  • Exosomal circRNAs are key regulators of the pre-metastatic microenvironment.
  • Mechanisms include immunosuppression, vascular permeability, ECM remodeling, and lymphangiogenesis.
  • This review is the first to focus on exosomal circRNAs in pre-metastatic niche regulation.

Conclusions

  • Exosomal circRNAs play critical roles in establishing the pre-metastatic niche.
  • Targeting exosomal circRNAs presents a promising strategy to inhibit cancer metastasis.
  • Further research into exosomal circRNA mechanisms can guide novel anti-metastatic therapies.

Keywords:

Related Concept Videos

lncRNA - Long Non-coding RNAs 02:39

8.4K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Overview of Exosomes 01:36

2.7K

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

MicroRNAs 01:22

2.9K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

The Tumor Microenvironment 02:17

6.4K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Metastasis 02:30

5.4K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

mTOR Signaling and Cancer Progression 03:03

3.6K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...